Questions and Answers.pdf
PDF 102 KB Posted
- Solicitation number
- W913E525R0007
About this file
This document is a Questions and Answers (Q&A) file for Solicitation No. W913E525R0007, providing clarifications for a potential Blanket Purchase Agreement (BPA) related to scientific research services. The Q&A addresses technical specifications for RNA sequencing, including acceptable read lengths (2x150bp is confirmed as suitable), preferred RNA-seq workflow (PolyA), and analytical methodology flexibility. Specifically, the government indicates that partial methodology coverage would still allow competitiveness, and that the first transcriptomics order is estimated to involve 36 samples in one batch and 50 samples in a second batch. Regarding pricing, the government recommends submitting a standard price list for the master BPA, with more detailed sample quotes to be provided once specific sample numbers and methodologies are determined.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| B08.02 W913E525R0007.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Solicitation No.: W913E525R0007 Questions and Answers:
1. Our standard sequencing read length for RNA-seq is 2x150 bp which is suitable for most applications – is there a specific need for 2x250 bp to be competitive for this BPA or would 2x150bp be acceptable?
Answer: 2x150bp would be acceptable
2. Is the RNA-seq workflow requested PolyA or rRNA depletion based? Or are both acceptable?
Answer: PolyA is preferred
3. Is GC-MS capability required to be competitive, or would we still be competitive if we only offered an LC/MS methodology that covered most compounds also detected by GC/MS?
Answer: Only meeting some of the methodologies requested would make the offeror competitive since some BPA orders may only request one method from the master BPA.
4. The instructions to us offerors request a price list. We can include our standard and published list prices, or instead some sample quotes of what the offerings end up looking like when invoiced for a contracting opportunity like this we would be eager to win. Do you have a preference? Would it be best to just include both?
Answer: The standard price list should be fine for the master BPA. The individual BPA orders would benefit from the more specific sample quote once we have number of samples and methodologies requested.
5. What is the estimated number of transcriptomics samples and batch sizes to be analyzed?
Answer: Estimated number of samples for the first transcriptomics order is 36 in one batch and 50 samples in a second batch.
File details come from the government source that posted it. Updated .